Загрузка...
Economic evaluation of biosimilars for reimbursement purposes – what, when, how?
Background: Limited previous research and guidelines on the design of economic evaluation for biosimilars have led to unresolved methodological questions on how to assess biosimilars. Objectives: We want to raise awareness of and explore methodological issues for the economic evaluation of biosimila...
Сохранить в:
| Опубликовано в: : | J Mark Access Health Policy |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Routledge
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7144192/ https://ncbi.nlm.nih.gov/pubmed/32284827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2020.1739509 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|